Trastuzumab Active Not Recruiting Phase 2 Trials for Cancer, Breast Prevention

IndicationsStatusPurposePhase
Active Not RecruitingPrevention2
clinicaltrials.gov IdentifierTitleDrugs
NCT02297698Phase II Trial of Combination Immunotherapy With NeuVax and Trastuzumab in High-risk HER2+ Breast Cancer Patients